Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Study Information
Alliance Study ID: A221101
NCT Study ID (ClinicalTrials.gov): NCT01781468
Alliance Committee: Cancer Control
Disease or Cancer Type: Brain / Central Nervous System Cancer
Alliance Study Chair: Alyx B. Porter Umphrey, MD
Status: COMPLETED
Study Description
This randomized phase III trial studies armodafinil to see how well it works in reducing cancer-related fatigue in patients with high grade glioma. Armodafinil may help relieve fatigue in patients with high grade glioma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information